Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Faculty

Paul J (PJ) Utz, Ph.D. Collaborator: Project 2 Assistant Professor of Medicine, Division of Rheumatology and Immunology Stanford University CCSR, 2215A 269 Campus Drive Stanford, California, 94305-5151 Phone: (650) 724-6743 (Lab) Fax: (650) 723-7509 Email: pjutz@stanford.edu

Investigator: Project 2, Assistant Professor of Medicine, Division of Rheumatology and Immunology (Stanford)
While earning his M.D. degree in 1991 from Stanford, Dr. Utz co-discovered the transcription factor Nuclear Factor of Activated T Cells (NFAT) with J.P. Shaw in Dr. Gerald Crabtree's laboratory. He completed his internal medicine residency, rheumatology fellowship, and post-doctoral training at Brigham and Women's Hospital in Boston prior to joining the Harvard Medical School Faculty in 1996. He left Dr. Paul Anderson's lab in 1999, and began experiments in his lab at Stanford in Spring 2000. Dr. Utz has expertise in the study of human and murine autoantibodies and autoantigens, apoptosis signaling pathways, animal models of autoimmunity, proteomics and microfluidics. Members of his laboratory are developing several cutting-edge proteomics technologies for immunological applications, including multiplex planar-based autoantigen microarrays for studying lupus, multiple sclerosis, Rheumatoid Arthritis, and other diseases such as diabetes, sclerosing cholanitis, and inflammatory bowel disease; reverse phase protein lysate microarrays for studying blood cells; and microfluidic capillary electrophoresis assays. His lab has collaborated with Hongjie Dai's lab for the last 3 years, describing the first clinically relevant use of carbon nanotubes for clinical immunology assays. He is actively involved with many educational programs within the University. He is director of the CCIS Summer High School Research Program, and provides formal lectures to undergraduate, graduate, and medical students in the Schools of Medicine and Engineering. He also teaches medical students, residents and fellows in the clinics and on the in-patient wards. Professor Utz is a member of the Scientific Advisory Boards of several Bay Area biotechnology companies, including Bayhill Therapeutics, Inc. (Palo Alto, CA), Nano BioDynamics, Inc. (San Jose, CA) and Adeptient, Inc. (Los Altos, CA).

[ Back ]